TRIM33 and dermatomyositis: This rarity poses significant challenges for clinical management.<h4>Objective</h4>To report a unique case of parotid LEC emerging three years after a diagnosis of anti-TIF1γ-positive DM, followed by a post-oncologic DM recurrence.